글로벌 척추성형술 및 척추성형술 시장 – 2029년까지의 산업 동향 및 예측

 척추성형술 및 척추성형술 시장 분석 및 규모

국제 골다공증 재단에 따르면 골다공증은 전 세계적으로 890만 건 이상의 골절을 유발합니다. 척추 압박 골절은 미국에서 매년 약 750,000명에게 영향을 미치는 골다공증의 흔한 징후이며, 대부분이 여성입니다. 골다공증성 척추 압박 골절은 심각한 기형과 부동성 합병증을 일으킬 수 있습니다. 보수적 치료에 저항하는 극심한 통증이 있는 환자는 척추 증강 수술의 혜택을 볼 수 있습니다.

Data Bridge Market Research는 2021년에 8억 495만 달러였던 척추성형술 및 척추후만증 수술 시장이 2029년까지 11억 7,127만 달러에 도달할 것으로 분석했으며, 2022년부터 2029년까지의 예측 기간 동안 연평균 성장률은 4.80%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

척추성형술 및 척추성형술 시장 범위 및 세분화

시장 정의

Verteoplasty is a minimally invasive spinal procedure in which bone cement is injected through a small hole in the skin into a fractured vertebra. Vertebroplasty relieves pain caused by compression fractures and stabilises the spine, thereby preventing further spinal dysfunction and improving quality of life. Kyphoplasty, is a type of spinal augmentation for compression fractures. This procedure relieves the pain caused by a vertebral fracture, stabilises the bone, and restores the height of the vertebral body, which has been reduced due to a compression fracture. Bone cement, also known as polymethyl-methacrylate, is injected into the fractured bone via a hollow needle during vertebroplasty.

In kyphoplasty, a balloon is inserted and inflated to expand the compressed vertebrae to their normal height, and then the space is filled with bone cement. Kyphosis is a modern spine surgery procedure used to stabilise vertebral compression fractures caused by osteoporosis, cancer, and other conditions.

Global Vertebroplasty and Kyphoplasty Market Dynamics

Drivers

• Launch of new products

Rising product launches, partnerships, and acquisitions by top market players are expected to boost segment growth. For instance, Medtronic plc launched its Kyphon Assist Directional Cannula in the United States in May 2020 to treat spinal compression fractures caused by osteoporosis, cancer, or benign lesions. As a result, these factors are expected to drive the growth of the kyphoplasty devices in the market.

• Surge in adoption of technologically advanced products

Medical device advancements have allowed for the reconstruction of various equipment, such as Crosstrees Medical, Inc.'s PVA Pod System, a novel bone cement delivery technology that does not require an implanted device in the spine. Medtronic's Khphon bone cement has been available with a new indication for sacral vertebral fracture since June 2018. The use of vertebroplasty and kyphoplasty equipment in the health care industry is increasing due to new applications of existing devices and the development of new devices. This equipment is used to perform various spine surgeries. This is driving the vertebroplasty and kyphoplasty market.

Opportunities

• Rising geriatric population will act as an opportunity

In recent years, the geriatric population has grown. According to the World Health Organization's October 2021 update, one in every six people worldwide is expected to be 60 or older by 2030. At this point, the proportion of the population aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion. The world's population of people aged 60 and up is expected to double by 2050. (2.1 billion). The number of people aged 80 and up is expected to triple between 2020 and 2050, reaching 426 million. The most common fractures in osteoporosis patients are vertebral compression fractures, the geriatric population is more prone to osteoporosis. As a result, the market is expected to grow.

Restraints/Challenges

• High cost of treatment

Spinal surgeries are extremely expensive and in some cases, are not covered by insurance. This increases the burden on the patient and family, making it unaffordable for low-income people. In the United States, for instance, the cost of lumbar fusion spine surgery exceeds $45,000, which does not include the costs of imaging, diagnostics, medications, hospital care, and rehabilitation services, among other things.

This vertebroplasty and kyphoplasty market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vertebroplasty and kyphoplasty market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Vertebroplasty and Kyphoplasty Market

COVID-19 has spread throughout the world and has met the epidemiologic criteria for a pandemic. In this terrifying situation, standard medical practise was severely impacted, emphasising the treatment of coronavirus patients. The spine section was completely reorganised to reduce the rate of contamination of medical staff and patients during hospitalisation. The North American Spine Society (NASS) issued a guidance document in April 2020 that included clinical considerations and recommendations for surgeries and procedures classified as emergent, urgent, or elective.

Recent developments

• In April 2022, Nanox announced FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density, which are frequently associated with osteoporosis.
• In August 2020, IZI Medical Products launched a osteo-site vertebral balloon ("Osteo-Site Balloon") for vertebral augmentation. It rounds out IZI's treatment options for vertebral compression fracture (VCF), which also include osteo-site vertebroplasty, osteo-site balloon kyphoplasty, blazer curved needle augmentation, and Kiva PEEK Implant-based augmentation.
• In August 2021, IZI Medical Products, LLC announced the official launch of Vertefix HV Cement. Vertefix HV is a novel technology for vertebroplasty and kyphoplasty procedures that meets the demand for real-time flow visualisation during cement injection. Product introductions are expected to boost market growth.

Global Vertebroplasty and Kyphoplasty Market Scope

The vertebroplasty and kyphoplasty market is segmented on the basis of product, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Vertebroplasty
• Needles
•  Cement mixing
•  Delivery device
• Kyphoplasty
• Needles and balloons
• Cement mixing
• Delivery device

End-Use

• Hospitals
• Ambulatory Surgery Centres

Vertebroplasty and Kyphoplasty Market Regional Analysis/Insights

The vertebroplasty and kyphoplasty market is analysed and market size insights and trends are provided by country, product, end-user and application as referenced above.

The countries covered in the vertebroplasty and kyphoplasty market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the vertebroplasty and kyphoplasty market owing to factors such as better healthcare infrastructure, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the United States.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to increasing older population and growing acceptance of the procedure are aiding the market growth. Similarly, factors such as availability of advanced methods in fracture stabilization, limitations of the conventional approach, increasing incidence of vertebral compression fracture, rising cases of osteoporosis.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

척추성형술 및 척추성형술 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 척추성형술 및 척추성형술 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 척추성형술 및 척추성형술 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 척추성형술 및 척추성형술 시장 점유율 분석

척추성형술 및 척추성형술 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 척추성형술 및 척추성형술 시장과 관련된 회사의 초점에만 관련이 있습니다.

척추성형술 및 척추후만증 수술 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 메드트로닉(아일랜드)
• Alphatec Spine, Inc(미국)
• 스트라이커(미국)
• 메리트 메디컬 시스템(미국)
• 글로버스 메디컬(미국)
• IZI 의료 제품(미국)
• 자베이션(미국)
• 론티스(스위스)
• G21 Srl(이탈리아)
• SOMATEX Medical Technologies GmbH(독일)
• BPB MEDICA(이탈리아)
• Laurane Medical LLC(프랑스)
• 테크니메드(프랑스)
• 벤베뉴 메디컬(미국)
• 스파인 웨이브 주식회사(미국)
• MEDAID Inc. (싱가포르)
• 카디널 헬스(미국)
• Joimax GmbH(독일)

SKU-55919